Home  /  Resource Library  /  Patient Perspective on Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classical Hodgkin Lymphoma Treated with Multiagent Chemotherapy Regimens in the HD21 Trial

Patient Perspective on Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classical Hodgkin Lymphoma Treated with Multiagent Chemotherapy Regimens in the HD21 Trial

Study investigated peripheral neuropathy in patients with Hodgkin lymphoma.